Ambitious as that may be, it is really just the tip of the iceberg. In addition to mapping out prostate and pancreatic cancer, Berg hopes to analyze data from a whole host of other diseases, including breast cancer. Additionally, Berg thinks his company's artificial intelligence platform can also revolutionize drug testing by creating individualized patient-specific treatment options, which he believes will ultimately reduce the risk of adverse drug interactions in clinical trials and hospitals by a significant degree.

这个目标本身可谓雄心勃勃，但它还只是冰山的一角。除了治疗前列腺癌和胰腺癌之外，伯格公司还希望分析多种其它疾病的数据，包括乳腺癌。另外，伯格公司还认为，它的人工智能平台可以根据病人的特异性制定专门针对个别患者的治疗方案，从而将掀起一场药物测试的革命，并显著降低药物的负面作用在临床实验和医疗实践中的风险。

I sat down with Berg and Narain to discuss how the company works and what they hope to accomplish in the next few years. The following interview has been edited for publication.

我采访了卡尔·伯格和纳雷因，探讨了该公司的工作机制，以及他们在未来几年内的目标。以下是采访摘要。

Fortune: Carl, why did you decide to move from real estate into healthcare and has it panned out like you thought it would?

财富：卡尔，你为什么选择从房地产业转向医疗行业？它的进展是否符合你的预期？

【人类能否在两三年内治愈癌症】相关文章：

★ 饮酒作乐已成过去 如今年轻人休假爱晒照

★ 让人越吃越年轻的食物

★ 年轻人由于肥胖问题,患癌率飙升

★ 哪些瓜果的皮能吃,但没人知道?

★ 我为什么不再和婆婆争来争去了?

★ 中国的这件羽绒服在国外超火爆！老外都赞不绝口

★ 如何戒除咖啡因瘾

★ Twitter会降低学生的考试成绩，那对其他人有什么影响

★ 今天会是美好的一天

★ Wi-Fi到底代表什么？